| Dr Richard Donald Alessi, MD | |
|
1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524-4000 | |
| (970) 224-2985 | |
| (970) 472-9381 |
| Full Name | Dr Richard Donald Alessi |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 1236 E Elizabeth St, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063409860 | NPI | - | NPPES |
| 01355908 | Medicaid | CO | |
| 112632600 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | DR.0035590 (Colorado) | Primary |
| 207L00000X | Anesthesiology | 252038 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Colorado Anesthesia Professionals Pllc | 6800878760 | 139 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells. By decoding this genomic data and looking for deletions and mutations associated with cancer, the research team believes this discovery could be translated into a test that helps physicians detect cancer and treat patients.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 1 days ago
| Entity Name | Yampa Valley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790787307 PECOS PAC ID: 5890685689 Enrollment ID: O20040316001301 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells. By decoding this genomic data and looking for deletions and mutations associated with cancer, the research team believes this discovery could be translated into a test that helps physicians detect cancer and treat patients.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 1 days ago
| Entity Name | Northern Colorado Anesthesia Professionals Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851389613 PECOS PAC ID: 6800878760 Enrollment ID: O20040603001119 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells. By decoding this genomic data and looking for deletions and mutations associated with cancer, the research team believes this discovery could be translated into a test that helps physicians detect cancer and treat patients.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Donald Alessi, MD 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524-4000 Ph: (970) 224-2985 | Dr Richard Donald Alessi, MD 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524-4000 Ph: (970) 224-2985 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells. By decoding this genomic data and looking for deletions and mutations associated with cancer, the research team believes this discovery could be translated into a test that helps physicians detect cancer and treat patients.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 1 days ago
Dr. Richard F Bindseil, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524 Phone: 970-224-2985 | |
Dr. Duane L. Dunn, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524 Phone: 970-224-2985 Fax: 970-472-9381 | |
Dr. Dwain Donavan Watrous, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524 Phone: 970-224-2985 Fax: 970-472-9381 | |
Dr. Kymberlee Royals, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4700 Lady Moon Dr, Fort Collins, CO 80528 Phone: 970-420-0905 | |
Dr. John Carter Bradley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1236 E Elizabeth St, Suite 2, Fort Collins, CO 80524 Phone: 970-488-1668 | |
Dr. David B Powell, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1236 E Elizabeth St, Suite 1, Fort Collins, CO 80524 Phone: 970-224-2985 Fax: 970-472-9381 |